Tuesday, March 29, 2011
SEC Charges FDA Chemist with Insider Trading
The Securities and Exchange Commission has charged a Food and Drug Administration chemist who worked on new drug applications with at least 27 instances of trading in 19 company stocks ahead of FDA approval announcements.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment